Prudential Financial’s Artiva Biotherapeutics ARTV Stock Holding History
Bought
Maintained
Sold
Other funds holding ARTV
Prudential Financial's ARTV Position: Q3 2026 in Review
Prudential Financial opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 97,505 shares worth $694K. The stake represents ﹤0.01% of the portfolio and ranks #1821 among its holdings.
96 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.
- Prudential Financial held 97,505 shares of Artiva Biotherapeutics worth $694K as of Q3 2026.
- Artiva Biotherapeutics was a new Prudential Financial position in Q3 2026.
- Artiva Biotherapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #1821 holding.
- 96 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.